Hydrogel delivery of sting immunotherapy for treatment cancer
dc.contributor.assignee | Rice University | en_US |
dc.contributor.assignee | The Board of Regents of the University of Texas System | en_US |
dc.contributor.publisher | United States Patent and Trademark Office | en_US |
dc.creator | Young, Simon | en_US |
dc.creator | Leach, David | en_US |
dc.creator | Hartgerink, Jeffrey D. | en_US |
dc.date.accessioned | 2024-05-02T16:55:22Z | en_US |
dc.date.available | 2024-05-02T16:55:22Z | en_US |
dc.date.filed | 2018-06-15 | en_US |
dc.date.issued | 2024-04-30 | en_US |
dc.description.abstract | In one aspect, the present disclosure provides for novel compositions of matter comprising multi domain peptide (MDP) hydrogels and cyclic dinucleotides (CDNs). Also disclosed are method of using such compositions in the treatment of cancer, including in particular the treatment of head and neck cancers, such as those resistant to CDN therapy. | en_US |
dc.digitization.specifications | This patent information was downloaded from the US Patent and Trademark website (http://www.uspto.gov/) as image-PDFs. The PDFs were OCRed for access purposes. | en_US |
dc.format.extent | 51 | en_US |
dc.identifier.patentID | US11969499B2 | en_US |
dc.identifier.uri | https://hdl.handle.net/1911/115490 | en_US |
dc.language.iso | eng | en_US |
dc.title | Hydrogel delivery of sting immunotherapy for treatment cancer | en_US |
dc.type | Utility patent | en_US |
dc.type.dcmi | Text | en_US |
dc.type.genre | patents | en_US |